Back

Stryker Corporation

Ticker: SYK ISIN: US8636671013
Add to portfolio Portfolio analysis in 2min
Stock Large-cap Dividend payer
Market cap
$127.41B
P/E
39.70
Forward P/E
22.37
Profit margin
12.92%
Revenue growth QoQ
11.40%
Div. yield
1.04%
Beta
0.87
$330.69 2.66%
Price as of 2026-08-28 · NYSE

Performance by timeframe

Rolling returns
1 Month -3.08%
6 Months -14.09%
1 Year -14.33%
5 Years +4.72% p.a.+25.90%
10 Years +12.33% p.a.+219.49%
Since inception +11.66% p.a.+1,469.53%
Calendar year returns
YTD -5.41%
2025 -1.48%
2024 +21.34%
2023 +23.80%
2022 -7.42%
2021 +10.22%

Key stats

Market cap
127.41B
P/E
39.70
Dividend yield
1.04%
Beta
0.87
52-week range
324.93 - 402.95
50-day MA
363.32
200-day MA
372.67
Section 1

Business overview

Company profile data from fundamentals.

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Sector Healthcare
Industry Medical Devices
Country United States
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 15.08%
ROA 7.92%
Profit margin 12.92%
Operating margin 27.24%
PEG ratio 1.60
Revenue/share TTM 65.71
Revenue TTM 25.12B
EBITDA 6.95B
Gross profit TTM 16.34B
Beta 0.87

Valuation

Trailing P/E 39.70
Forward P/E 22.37
P/B 5.73
P/S 5.07
EV/EBITDA 22.21
EV/Revenue 5.58
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 14.97
Quarterly earnings growth 55.90%
Revenue TTM 25.12B
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 1.04%
Dividend per share 3.4000
Next dividend date 2026-04-30
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Ownership & short interest

Short ratio 2.08
Short % of float 1.11%

Details

Instrument metadata and source update timestamps.

Symbol SYK
Name Stryker Corporation
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US8636671013
Country USA
Code + exchange SYK.NYSE
Last price date 2026-03-26
Fundamentals updated 2026-03-27

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.